Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.

Campi-Azevedo AC, Peruhype-Magalhāes V, Coelho-Dos-Reis JG, Antonelli LR, Costa-Pereira C, Speziali E, Reis LR, Lemos JA, Ribeiro JGL, Bastos Camacho LA, de Sousa Maia ML, Barbosa de Lima SM, Simões M, de Menezes Martins R, Homma A, Cota Malaquias LC, Tauil PL, Costa Vasconcelos PF, Martins Romano AP, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA; Collaborative Group for Studies of Yellow Fever Vaccine.

Emerg Infect Dis. 2019 Aug 17;25(8). doi: 10.3201/eid2508.181432. [Epub ahead of print]

PMID:
31298654
Free Article
2.

Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Fradico JRB, Souza-Lopes T, Reis LR, Freire LC, Costa-Pereira C, Mambrini JVM, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, de Castro TDM, Homma A, Romano APM, Domingues CM, Martins RM, Teixeira-Carvalho A, Martins-Filho OA.

Front Immunol. 2019 Jun 21;10:1211. doi: 10.3389/fimmu.2019.01211. eCollection 2019.

PMID:
31293563
Free PMC Article
3.

Differentiation Between Eosinophilic Otitis Media and Otitis Media Associated With Eosinophilic Granulomatosis With Polyangiitis.

Fukuda A, Morita S, Nakamaru Y, Hoshino K, Fujiwara K, Homma A.

Otol Neurotol. 2019 Jul 8. doi: 10.1097/MAO.0000000000002295. [Epub ahead of print]

PMID:
31290803
4.

Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.

Hernandez N, Bucciol G, Moens L, Le Pen J, Shahrooei M, Goudouris E, Shirkani A, Changi-Ashtiani M, Rokni-Zadeh H, Sayar EH, Reisli I, Lefevre-Utile A, Zijlmans D, Jurado A, Pholien R, Drutman S, Belkaya S, Cobat A, Boudewijns R, Jochmans D, Neyts J, Seeleuthner Y, Lorenzo-Diaz L, Enemchukwu C, Tietjen I, Hoffmann HH, Momenilandi M, Pöyhönen L, Siqueira MM, de Lima SMB, de Souza Matos DC, Homma A, Maia MLS, da Costa Barros TA, de Oliveira PMN, Mesquita EC, Gijsbers R, Zhang SY, Seligman SJ, Abel L, Hertzog P, Marr N, Martins RM, Meyts I, Zhang Q, MacDonald MR, Rice CM, Casanova JL, Jouanguy E, Bossuyt X.

J Exp Med. 2019 Jul 3. pii: jem.20182295. doi: 10.1084/jem.20182295. [Epub ahead of print]

PMID:
31270247
5.

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, Kiyota N, Homma A, Holeckova P, Del Campo JM, Asarawala N, Nicolau UR, Rauch D, Even C, Wang B, Gibson N, Ehrnrooth E, Harrington K, Cohen EEW; LUX-Head & Neck 2 investigators.

JAMA Oncol. 2019 Jun 13. doi: 10.1001/jamaoncol.2019.1146. [Epub ahead of print]

PMID:
31194247
6.

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition).

Head and Neck Cancer Study Group (HNCSG), Monden N, Asakage T, Kiyota N, Homma A, Matsuura K, Hanai N, Kodaira T, Zenda S, Fujii H, Tahara M, Yokota T, Akimoto T, Iwae S, Onitsuka T, Ogawa T, Okano S, Takahashi S, Shimizu Y, Yonezawa K, Hayashi R.

Jpn J Clin Oncol. 2019 Jun 13. pii: hyz052. doi: 10.1093/jjco/hyz052. [Epub ahead of print]

PMID:
31194232
7.

Machine-Learning-Based Prediction of Treatment Outcomes Using MR Imaging-Derived Quantitative Tumor Information in Patients with Sinonasal Squamous Cell Carcinomas: A Preliminary Study.

Fujima N, Shimizu Y, Yoshida D, Kano S, Mizumachi T, Homma A, Yasuda K, Onimaru R, Sakai O, Kudo K, Shirato H.

Cancers (Basel). 2019 Jun 10;11(6). pii: E800. doi: 10.3390/cancers11060800.

8.

[A Nutritional Supplement with a High Blend Ratio of ω-3 Fatty Acids(Prosure®) Reduces Severe Oral Mucositis and Body Weight Loss for Head and Neck Cancer Patients Treated with Chemoradiotherapy].

Mizumachi T, Kano S, Homma A, Akazawa M, Hasegawa C, Shiroishi Y, Okamoto C, Kumagai S, Nishimura M, Takasaki H, Takeda H, Yasuda K, Minatogawa H, Dekura Y, Onimaru R, Shirato H, Fukuda S.

Gan To Kagaku Ryoho. 2019 Apr;46(4):685-689. Japanese.

PMID:
31164507
9.

Desmoplastic small round cell tumor of the parotid gland-report of a rare case and a review of the literature.

Hatanaka KC, Takakuwa E, Hatanaka Y, Suzuki A, IIzuka S, Tsushima N, Mitsuhashi T, Sugita S, Homma A, Morinaga S, Hashegawa T, Matsuno Y.

Diagn Pathol. 2019 May 18;14(1):43. doi: 10.1186/s13000-019-0825-1.

10.

Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System.

Fukuda A, Morita S, Nakamaru Y, Hoshino K, Fujiwara K, Homma A.

J Int Adv Otol. 2019 Apr;15(1):2-7. doi: 10.5152/iao.2019.5983.

11.

Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines.

Borges MB, Marchevsky RS, Carvalho Pereira R, da Silva Mendes Y, Almeida Mendes LG, Diniz-Mendes L, Cruz MA, Tahmaoui O, Baudart S, Freire M, Homma A, Schneider-Ohrum K, Vaughn DW, Vanloubbeeck Y, Lorin C, Malice MP, Caride E, Warter L.

PLoS Pathog. 2019 Apr 22;15(4):e1007721. doi: 10.1371/journal.ppat.1007721. eCollection 2019 Apr.

12.

The utility of MRI histogram and texture analysis for the prediction of histological diagnosis in head and neck malignancies.

Fujima N, Homma A, Harada T, Shimizu Y, Tha KK, Kano S, Mizumachi T, Li R, Kudo K, Shirato H.

Cancer Imaging. 2019 Feb 4;19(1):5. doi: 10.1186/s40644-019-0193-9.

13.

Controversies in relation to neck management in N0 early oral tongue cancer.

Hanai N, Asakage T, Kiyota N, Homma A, Hayashi R.

Jpn J Clin Oncol. 2019 Apr 1;49(4):297-305. doi: 10.1093/jjco/hyy196. Review.

PMID:
30668761
14.

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Hamauchi S, Yokota T, Mizumachi T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H, Homma A.

Int J Clin Oncol. 2019 May;24(5):468-475. doi: 10.1007/s10147-018-01392-9. Epub 2019 Jan 17.

PMID:
30656463
15.

The Diagnostic and Clinical Utility of the Myeloperoxidase-DNA Complex as a Biomarker in Otitis Media With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Morita S, Nakamaru Y, Nakazawa D, Suzuki M, Hoshino K, Fukuda A, Hattanda F, Kusunoki K, Tomaru U, Ishizu A, Homma A.

Otol Neurotol. 2019 Feb;40(2):e99-e106. doi: 10.1097/MAO.0000000000002081.

PMID:
30570611
16.

Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation.

Possas C, Lourenço-de-Oliveira R, Tauil PL, Pinheiro FP, Pissinatti A, Cunha RVD, Freire M, Martins RM, Homma A.

Mem Inst Oswaldo Cruz. 2018 Sep 3;113(10):e180278. doi: 10.1590/0074-02760180278. Review.

17.

Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.

Yanagi T, Watanabe M, Hata H, Kitamura S, Imafuku K, Yanagi H, Homma A, Wang L, Takahashi H, Shimizu H, Hatakeyama S.

Cancer Res. 2018 Dec 15;78(24):6795-6806. doi: 10.1158/0008-5472.CAN-18-1495. Epub 2018 Nov 2.

PMID:
30389700
18.

Evaluation of Vertical Semicircular Canal Function in Patients With Vestibular Schwannoma.

Fujiwara K, Yanagi H, Morita S, Hoshino K, Fukuda A, Nakamaru Y, Homma A.

Ann Otol Rhinol Laryngol. 2019 Feb;128(2):113-120. doi: 10.1177/0003489418808545. Epub 2018 Oct 26.

PMID:
30360640
19.

Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND).

Tanaka K, Hanai N, Eba J, Mizusawa J, Asakage T, Homma A, Kiyota N, Fukuda H, Hayashi R; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2018 Dec 1;48(12):1105-1108. doi: 10.1093/jjco/hyy125.

PMID:
30346569
20.

Semi-quantitative analysis of pre-treatment morphological and intratumoral characteristics using 18F-fluorodeoxyglucose positron-emission tomography as predictors of treatment outcome in nasal and paranasal squamous cell carcinoma.

Fujima N, Hirata K, Shiga T, Yasuda K, Onimaru R, Tsuchiya K, Kano S, Mizumachi T, Homma A, Kudo K, Shirato H.

Quant Imaging Med Surg. 2018 Sep;8(8):788-795. doi: 10.21037/qims.2018.09.09.

21.

Integrating quantitative morphological and intratumoural textural characteristics in FDG-PET for the prediction of prognosis in pharynx squamous cell carcinoma patients.

Fujima N, Hirata K, Shiga T, Li R, Yasuda K, Onimaru R, Tsuchiya K, Kano S, Mizumachi T, Homma A, Kudo K, Shirato H.

Clin Radiol. 2018 Dec;73(12):1059.e1-1059.e8. doi: 10.1016/j.crad.2018.08.011. Epub 2018 Sep 21.

PMID:
30245069
22.

Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study.

Takeuchi S, Shiga T, Hirata K, Taguchi J, Magota K, Ariga S, Gouda T, Ohhara Y, Homma R, Shimizu Y, Kinoshita I, Tsuji Y, Homma A, Iijima H, Tamaki N, Dosaka-Akita H.

BMJ Open. 2018 Aug 30;8(8):e021001. doi: 10.1136/bmjopen-2017-021001.

23.

Oncocytoma of the Parotid Gland with Facial Nerve Paralysis.

Hamada S, Fujiwara K, Hatakeyama H, Homma A.

Case Rep Otolaryngol. 2018 Jun 21;2018:7687951. doi: 10.1155/2018/7687951. eCollection 2018.

24.

Sanger-based sequencing technology for yellow fever vaccine genetic quality control.

Pestana CP, Lawson-Ferreira R, Lessa-Aquino C, Leal MDLF, Freire MDS, Homma A, Medeiros MA.

J Virol Methods. 2018 Oct;260:82-87. doi: 10.1016/j.jviromet.2018.07.006. Epub 2018 Jul 26.

PMID:
30009851
25.

Intra-arterial Chemoradiation Therapy as an Option for Maxillary Sinus Cancers.

Homma A, Onimaru R.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):763. doi: 10.1016/j.ijrobp.2018.03.051. Epub 2018 Jun 20. No abstract available.

PMID:
29976485
26.

Comparison of the University of Pittsburgh staging system and the eighth edition of the American Joint Committee on Cancer TNM classification for the prognostic evaluation of external auditory canal cancer.

Morita S, Mizumachi T, Nakamaru Y, Sakashita T, Kano S, Hoshino K, Fukuda A, Fujiwara K, Homma A.

Int J Clin Oncol. 2018 Dec;23(6):1029-1037. doi: 10.1007/s10147-018-1314-3. Epub 2018 Jul 5.

PMID:
29974295
27.

HIV cure: global overview of bNAbs' patents and related scientific publications.

Possas C, Antunes AMS, Lins Mendes FM, Veloso V, Martins RM, Homma A.

Expert Opin Ther Pat. 2018 Jul;28(7):551-560. doi: 10.1080/13543776.2018.1495708. Review.

PMID:
29962249
28.

Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination.

Costa-Pereira C, Campi-Azevedo AC, Coelho-Dos-Reis JG, Peruhype-Magalhães V, Araújo MSS, do Vale Antonelli LR, Fonseca CT, Lemos JA, Malaquias LCC, de Souza Gomes M, Rodrigues Amaral L, Rios M, Chancey C, Persi HR, Pereira JM, de Sousa Maia ML, Freire MDS, Martins RM, Homma A, Simões M, Yamamura AY, Farias RHG, Romano APM, Domingues CM, Tauil PL, Vasconcelos PFC, Caldas IR, Camacho LA, Teixeira-Carvalho A, Martins-Filho OA.

PLoS Negl Trop Dis. 2018 Jun 7;12(6):e0006462. doi: 10.1371/journal.pntd.0006462. eCollection 2018 Jun.

29.

Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.

de Menezes Martins R, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, da Matta de Castro T, Homma A; Collaborative Group for Studies on Duration of Immunity from Yellow Fever Vaccine.

Vaccine. 2018 Jun 27;36(28):4112-4117. doi: 10.1016/j.vaccine.2018.05.041. Epub 2018 May 18.

30.

Genetic mutation analysis of the malignant transformation of sinonasal inverted papilloma by targeted amplicon sequencing.

Yasukawa S, Kano S, Hatakeyama H, Nakamaru Y, Takagi D, Mizumachi T, Suzuki M, Suzuki T, Nakazono A, Tanaka S, Nishihara H, Homma A.

Int J Clin Oncol. 2018 Oct;23(5):835-843. doi: 10.1007/s10147-018-1296-1. Epub 2018 May 19.

31.

Sirtuin-1 Controls Poly (I:C)-Dependent Matrix Metalloproteinase 9 Activation in Primary Human Nasal Epithelial Cells.

Suzuki M, Ramezanpour M, Cooksley C, Li J, Nakamaru Y, Homma A, Psaltis A, Wormald PJ, Vreugde S.

Am J Respir Cell Mol Biol. 2018 Oct;59(4):500-510. doi: 10.1165/rcmb.2017-0415OC.

PMID:
29767533
32.

Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques.

Borges MB, Marchevsky RS, Mendes YS, Mendes LG, Duarte AC, Cruz M, de Filippis AMB, Vasconcelos PFC, Freire M, Homma A, Mossman S, Lepine E, Vanloubbeeck Y, Lorin C, Malice MP, Caride E, Warter L.

PLoS One. 2018 Apr 25;13(4):e0196311. doi: 10.1371/journal.pone.0196311. eCollection 2018.

33.

Validation of the 8th edition of the AJCC/UICC TNM staging system for tongue squamous cell carcinoma.

Kano S, Sakashita T, Tsushima N, Mizumachi T, Nakazono A, Suzuki T, Yasukawa S, Homma A.

Int J Clin Oncol. 2018 Oct;23(5):844-850. doi: 10.1007/s10147-018-1276-5. Epub 2018 Apr 19.

34.

The surgical outcome of minimally invasive pharyngo-laryngo-oesophagectomy in prone position.

Ogino M, Ebihara Y, Homma A, Tanaka K, Nakanishi Y, Asano T, Noji T, Kurashima Y, Murakami S, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S.

J Minim Access Surg. 2018 Mar 23. doi: 10.4103/jmas.JMAS_230_17. [Epub ahead of print]

35.

Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV.

Mizushima T, Ohnishi S, Shimizu Y, Hatanaka Y, Hatanaka KC, Kuriki Y, Kamiya M, Homma A, Yamamoto K, Ono S, Urano Y, Sakamoto N.

Head Neck. 2018 Jul;40(7):1466-1475. doi: 10.1002/hed.25126. Epub 2018 Mar 6.

PMID:
29509281
36.

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).

Tahara M, Kiyota N, Yokota T, Hasegawa Y, Muro K, Takahashi S, Onoe T, Homma A, Taguchi J, Suzuki M, Minato K, Yane K, Ueda S, Hara H, Saijo K, Yamanaka T.

Ann Oncol. 2018 Apr 1;29(4):1004-1009. doi: 10.1093/annonc/mdy040.

PMID:
29408977
37.

Elevated Level of Myeloperoxidase-Deoxyribonucleic Acid Complex in the Middle Ear Fluid Obtained From Patients With Otitis Media Associated With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Morita S, Nakamaru Y, Nakazawa D, Hattanda F, Shida H, Kusunoki Y, Watanabe K, Masuda S, Takagi D, Suzuki M, Hoshino K, Fukuda A, Tomaru U, Homma A, Ishizu A.

Otol Neurotol. 2018 Apr;39(4):e257-e262. doi: 10.1097/MAO.0000000000001708.

PMID:
29342044
38.

Anti-mumps IgM antibody positive rate with sudden sensorineural hearing loss using second-generation enzyme immunoassay: A retrospective, multi-institutional investigation in Hokkaido, Japan.

Fukuda A, Morita S, Nakamaru Y, Hoshino K, Fujiwara K, Akazawa S, Sakashita T, Obara N, Homma A.

Auris Nasus Larynx. 2018 Oct;45(5):911-915. doi: 10.1016/j.anl.2017.11.016. Epub 2017 Dec 8.

PMID:
29224848
39.

Clinical Characteristics and Treatment Outcomes for Patients With External Auditory Canal Cholesteatoma.

Morita S, Nakamaru Y, Fukuda A, Fujiwara K, Hoshino K, Homma A.

Otol Neurotol. 2018 Feb;39(2):189-195. doi: 10.1097/MAO.0000000000001659.

PMID:
29210949
40.

Urgent call for action: avoiding spread and re-urbanisation of yellow fever in Brazil.

Possas C, Martins RM, Oliveira RL, Homma A.

Mem Inst Oswaldo Cruz. 2018 Jan;113(1):1-2. doi: 10.1590/0074-02760170361. No abstract available.

41.

Easy Screening for Mild Alzheimer's Disease and Mild Cognitive Impairment from Elderly Speech.

Kato S, Homma A, Sakuma T.

Curr Alzheimer Res. 2018;15(2):104-110. doi: 10.2174/1567205014666171120144343.

PMID:
29165082
42.

Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.

Homma A, Onimaru R, Matsuura K, Shinomiya H, Sakashita T, Shiga K, Tachibana H, Nakamura K, Mizusawa J, Kitahara H, Eba J, Fukuda H, Fujii M, Hayashi R.

Head Neck. 2018 Mar;40(3):475-484. doi: 10.1002/hed.25001. Epub 2017 Nov 11.

43.

Value of T1-weighted Magnetic Resonance Imaging in Cholesteatoma Detection.

Fukuda A, Morita S, Harada T, Fujiwara K, Hoshino K, Nakamaru Y, Homma A.

Otol Neurotol. 2017 Dec;38(10):1440-1444. doi: 10.1097/MAO.0000000000001558.

PMID:
29084089
44.

Evaluation of Vestibular Functions in Patients with Vogt-Koyanagi-Harada Disease.

Fujiwara K, Morita S, Hoshino K, Fukuda A, Nakamaru Y, Homma A.

Audiol Neurootol. 2017;22(3):190-195. doi: 10.1159/000481426. Epub 2017 Oct 28.

PMID:
29080887
45.

Reliability and Validity of Speech Evaluation in Adductor Spasmodic Dysphonia.

Yanagida S, Nishizawa N, Hashimoto R, Mizoguchi K, Hatakeyama H, Homma A, Fukuda S.

J Voice. 2018 Sep;32(5):585-591. doi: 10.1016/j.jvoice.2017.06.022. Epub 2017 Aug 9.

PMID:
28802787
46.

Osteoradionecrosis of the hyoid bone after intra-arterial chemoradiotherapy for oropharyngeal cancer: MR imaging findings.

Hatakeyama H, Fujima N, Tsuchiya K, Mizoguchi K, Mizumachi T, Sakashita T, Kano S, Homma A, Fukuda S.

Cancer Imaging. 2017 Jul 27;17(1):22. doi: 10.1186/s40644-017-0123-7.

47.

Role of microRNA-296-3p in the malignant transformation of sinonasal inverted papilloma.

Kakizaki T, Hatakeyama H, Nakamaru Y, Takagi D, Mizumachi T, Sakashita T, Kano S, Homma A, Fukuda S.

Oncol Lett. 2017 Jul;14(1):987-992. doi: 10.3892/ol.2017.6193. Epub 2017 May 17.

48.

Matched-pair analysis of patients with advanced hypopharyngeal cancer: surgery versus concomitant chemoradiotherapy.

Iwae S, Fujii M, Hayashi R, Hasegawa Y, Fujii T, Okami K, Homma A, Onitsuka T, Kato T, Ogawa T, Terao K, Monden N, Otsuki N, Nishino H, Ota I, Fujimoto Y, Matsuura K, Kawabata K, Matsui H, Yonezawa K, Nibu KI.

Int J Clin Oncol. 2017 Dec;22(6):1001-1008. doi: 10.1007/s10147-017-1151-9. Epub 2017 Jun 17.

PMID:
28624863
49.

Residual tumour detection in post-treatment granulation tissue by using advanced diffusion models in head and neck squamous cell carcinoma patients.

Fujima N, Yoshida D, Sakashita T, Homma A, Kudo K, Shirato H.

Eur J Radiol. 2017 May;90:14-19. doi: 10.1016/j.ejrad.2017.02.025. Epub 2017 Feb 20.

50.

Atypical adenoma of the thyroid diagnosed as anaplastic cancer by cytopathology.

Hatakeyama H, Hoshino K, Mizoguchi K, Suzuki T, Hatanaka KC, Yamaya Y, Kano S, Mizumachi T, Homma A.

Diagn Cytopathol. 2017 Oct;45(10):928-933. doi: 10.1002/dc.23751. Epub 2017 May 22.

Supplemental Content

Support Center